Charlotte J. Yong‐Hing

Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-Octreotate

Samer Ezziddin, Mared Attassi, Charlotte J. Yong‐Hing et al. · Journal of Nuclear Medicine · 2014 · 191 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Dual-Energy CT as a Potential New Diagnostic Tool in the Management of Gout in the Acute Setting

Savvakis Nicolaou, Charlotte J. Yong‐Hing, Sandro Galea-Soler et al. · American Journal of Roentgenology · 2010 · 172 citations

Medicine, Radiology, Diagnostic Imaging +14

Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain

Charlotte J. Yong‐Hing, André Obenaus, Rodrick Stryker et al. · Magnetic Resonance in Medicine · 2005 · 110 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.

Samer Ezziddin, Timur Logvinski, Charlotte J. Yong‐Hing et al. · PubMed · 2006 · 89 citations

Medicine, Nuclear Medicine, Oncology +17

Does the Pretherapeutic Tumor SUV in 68Ga DOTATOC PET Predict the Absorbed Dose of 177Lu Octreotate?

Samer Ezziddin, Jonas Lohmar, Charlotte J. Yong‐Hing et al. · Clinical Nuclear Medicine · 2012 · 88 citations

Medicine, Nuclear Medicine, Radiology +17